HRP20000171B1 - Oral compositions of levosimendan - Google Patents

Oral compositions of levosimendan

Info

Publication number
HRP20000171B1
HRP20000171B1 HR20000171A HRP20000171A HRP20000171B1 HR P20000171 B1 HRP20000171 B1 HR P20000171B1 HR 20000171 A HR20000171 A HR 20000171A HR P20000171 A HRP20000171 A HR P20000171A HR P20000171 B1 HRP20000171 B1 HR P20000171B1
Authority
HR
Croatia
Prior art keywords
levosimendan
oral compositions
polymorphic form
crystalline polymorphic
demands
Prior art date
Application number
HR20000171A
Other languages
English (en)
Croatian (hr)
Inventor
Harjula Maarit
Larma Ilkka
Antila Saila
Lehtonen Lasse
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20000171A2 publication Critical patent/HRP20000171A2/hr
Publication of HRP20000171B1 publication Critical patent/HRP20000171B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
HR20000171A 1997-09-26 1998-09-24 Oral compositions of levosimendan HRP20000171B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI973804A FI973804A7 (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia
PCT/FI1998/000753 WO1999016443A1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Publications (2)

Publication Number Publication Date
HRP20000171A2 HRP20000171A2 (en) 2000-12-31
HRP20000171B1 true HRP20000171B1 (en) 2009-06-30

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000171A HRP20000171B1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Country Status (35)

Country Link
US (1) US6355269B1 (cs)
EP (1) EP1014987B1 (cs)
JP (1) JP4493840B2 (cs)
KR (1) KR100762022B1 (cs)
CN (1) CN1149994C (cs)
AR (1) AR013519A1 (cs)
AT (1) ATE260659T1 (cs)
AU (1) AU732489B2 (cs)
BG (1) BG64746B1 (cs)
BR (1) BR9813213A (cs)
CA (1) CA2304702C (cs)
CZ (1) CZ294984B6 (cs)
DE (1) DE69822172T2 (cs)
DK (1) DK1014987T3 (cs)
EA (1) EA001647B1 (cs)
EE (1) EE03854B1 (cs)
ES (1) ES2217580T3 (cs)
FI (1) FI973804A7 (cs)
GE (1) GEP20032943B (cs)
HR (1) HRP20000171B1 (cs)
HU (1) HUP0003757A3 (cs)
ID (1) ID24486A (cs)
IL (1) IL134802A (cs)
MX (1) MXPA00002956A (cs)
MY (1) MY118156A (cs)
NO (1) NO320047B1 (cs)
NZ (1) NZ503207A (cs)
PL (1) PL190862B1 (cs)
PT (1) PT1014987E (cs)
RS (1) RS49708B (cs)
SI (1) SI1014987T1 (cs)
SK (1) SK283187B6 (cs)
TR (1) TR200000635T2 (cs)
WO (1) WO1999016443A1 (cs)
YU (1) YU17700A (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
DK1347747T3 (da) * 2000-12-22 2006-04-10 Baxter Int Fremgangsmåde til behandling af submikropartikelsuspensioner af farmaceutiske midler
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
JP5747030B2 (ja) * 2009-07-14 2015-07-08 シプラ・リミテッド レボシメンダンの製造方法及びその方法で用いる中間体
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
AU2020408323A1 (en) * 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383449A2 (en) * 1989-02-11 1990-08-22 Orion-Yhtymà„ Oy Pyridazinone derivatives and processes for preparing the same
WO1992012135A1 (en) * 1991-01-03 1992-07-23 Orion-Yhtymä Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
WO1993021921A1 (en) * 1992-05-06 1993-11-11 Orion-Yhtymä Oy Anti-ischemic medicament
WO1997035841A2 (en) * 1996-03-27 1997-10-02 Orion-Yhtymä Oy Method for obtaining pure enantiomers of a pyridazinone derivative
WO1998001111A1 (en) * 1996-07-05 1998-01-15 Orion-Yhtymä Oy Transdermal compositions containing levosimendan

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383449A2 (en) * 1989-02-11 1990-08-22 Orion-Yhtymà„ Oy Pyridazinone derivatives and processes for preparing the same
WO1992012135A1 (en) * 1991-01-03 1992-07-23 Orion-Yhtymä Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
WO1993021921A1 (en) * 1992-05-06 1993-11-11 Orion-Yhtymä Oy Anti-ischemic medicament
WO1997035841A2 (en) * 1996-03-27 1997-10-02 Orion-Yhtymä Oy Method for obtaining pure enantiomers of a pyridazinone derivative
WO1998001111A1 (en) * 1996-07-05 1998-01-15 Orion-Yhtymä Oy Transdermal compositions containing levosimendan

Also Published As

Publication number Publication date
CA2304702A1 (en) 1999-04-08
WO1999016443A1 (en) 1999-04-08
AR013519A1 (es) 2000-12-27
EA200000360A1 (ru) 2000-10-30
GEP20032943B (en) 2003-04-25
FI973804A0 (fi) 1997-09-26
ES2217580T3 (es) 2004-11-01
HUP0003757A2 (hu) 2001-05-28
MXPA00002956A (es) 2003-05-19
SK283187B6 (sk) 2003-03-04
IL134802A (en) 2004-01-04
DK1014987T3 (da) 2004-05-24
SI1014987T1 (en) 2004-08-31
CN1271282A (zh) 2000-10-25
MY118156A (en) 2004-09-30
BR9813213A (pt) 2000-08-29
AU732489B2 (en) 2001-04-26
NO20001585D0 (no) 2000-03-27
CZ2000919A3 (cs) 2000-09-13
NO320047B1 (no) 2005-10-17
JP4493840B2 (ja) 2010-06-30
PL190862B1 (pl) 2006-02-28
CA2304702C (en) 2007-09-04
RS49708B (sr) 2007-12-31
IL134802A0 (en) 2001-04-30
BG104250A (en) 2000-12-29
KR20010030679A (ko) 2001-04-16
JP2001517702A (ja) 2001-10-09
CN1149994C (zh) 2004-05-19
EE03854B1 (et) 2002-10-15
PT1014987E (pt) 2004-06-30
KR100762022B1 (ko) 2007-09-28
DE69822172D1 (de) 2004-04-08
DE69822172T2 (de) 2005-02-24
HUP0003757A3 (en) 2001-07-30
HK1032001A1 (en) 2001-07-06
US6355269B1 (en) 2002-03-12
ID24486A (id) 2000-07-20
ATE260659T1 (de) 2004-03-15
YU17700A (sh) 2002-10-18
HRP20000171A2 (en) 2000-12-31
CZ294984B6 (cs) 2005-04-13
TR200000635T2 (tr) 2000-09-21
EP1014987B1 (en) 2004-03-03
NO20001585L (no) 2000-03-27
EP1014987A1 (en) 2000-07-05
EA001647B1 (ru) 2001-06-25
PL339461A1 (en) 2000-12-18
BG64746B1 (bg) 2006-02-28
SK3842000A3 (en) 2000-09-12
AU9350698A (en) 1999-04-23
FI973804A7 (fi) 1999-03-27
EE200000187A (et) 2001-04-16
NZ503207A (en) 2001-04-27

Similar Documents

Publication Publication Date Title
HRP20000171B1 (en) Oral compositions of levosimendan
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
BG105564A (en) Galantamine-containing composition with controlled release
IL115357A (en) Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
HUP9802822A3 (en) Halobenzimidazol derivatives, intermediates, preparation thereof and microbocide compositions containing these compounds as active ingredients
HUP9802304A3 (en) Pyridazin-3-one derivatives, intermediates, use thereof, insecticide compositions containing these compounds as active ingredients
TW359672B (en) Thienopyrimidines ad phosphodiesterase V antagonists, process for the production thereof and pharmaceutical compositions containing the same
IL117848A0 (en) Novel compounds a process for their production and pharmacetical compositions containing same
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
SE9504661D0 (sv) New compounds
CA2225601A1 (en) New stable pharmaceutical preparation for producing propellant-free aerosols
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
ES2103587T3 (es) Composiciones terapeuticas ingeribles, estables y absorbibles de nadh y de nadph.
BG103947A (en) Derivatives of 9-oxymerythromycin
RS51541B (sr) 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze
SI1121127T1 (en) Oral pharmaceutical compositions containing buprenorphin
HUP9802533A2 (hu) 3-6 Szénatomos alkolholt tartalmazó antimikrobiális szájápoló készítmények
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
CA2507743A1 (en) Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
MD502F1 (en) New adenozin derivatives, method for preparation, pharmaceutical baze compositions
ZA946196B (en) New bis-naphthalimides for the treatment of cancer
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100827

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20110925